Novavax (NVAX) FCF Margin Growth (5y) (2015 - 2026)
Novavax (NVAX) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-16,932.00 |
| Dec 31, 2025 |
1,811.00 |
| Sep 30, 2025 |
16,518.00 |
| Jun 30, 2025 |
-39,075.00 |
| Mar 31, 2025 |
65,997.00 |
| Dec 31, 2024 |
8,649.00 |
| Sep 30, 2024 |
111,734.00 |
| Jun 30, 2024 |
98,540.00 |
| Mar 31, 2024 |
119,476.00 |
| Dec 31, 2023 |
68,363.00 |
| Sep 30, 2023 |
41,385.00 |
| Jun 30, 2023 |
33,373.00 |
| Mar 31, 2023 |
25,939.00 |
| Dec 31, 2022 |
37,964.00 |
| Sep 30, 2022 |
49,866.00 |
| Jun 30, 2022 |
11,008.00 |
| Mar 31, 2022 |
78,752.00 |
| Sep 30, 2021 |
600,156.00 |
| Jun 30, 2021 |
250,702.00 |
| Mar 31, 2021 |
187,612.00 |
